injectables

Injecting Men

Understanding the unique anatomical characteristics of the male face is key to providing the best aesthetic outcomes with fillers and neurotoxins.
Injecting Men

An angular jaw with a prominent chin, eyes framed by a smattering of smile lines and a full brow—the male aesthetic ideal is distinctly different than the soft curves, arched brow and high cheekbones sought by female patients. Yet men do share the same desire as women to put their best faces forward, and by understanding their unique anatomical attributes you can use your existing range of injectables to deliver the subtle improvements they are seeking from their aesthetic providers.

Additive Effects

Research confirms that combining neurotoxin with hyaluronic acid fillers can enhance and prolong desired effects, but more study is needed to understand the mechanisms of action.
Additive Effects

A recent study from researchers at Ondokuz Mayis University, Samsun, Turkey, published in Plastic and Reconstructive Surgery (January 2016), concluded that combination treatment with botulinum toxin type A (BTX-A) and hyaluronic acid (HA) fillers slowed the degradation of the filler.

Phase 2b Trials Initiated for Injectable Cellulite Solution

Phase 2B Trials Initiated for Injectable Cellulite Solution

Pharmaceutical company Endo International has announced the initiation of its Phase 2b study of collagenase clostridium histolyticum (CCH) for the treatment of edematous fibrosclerotic panniculopathy (EFP), commonly known as cellulite. CCH (currently known as XIAFLEX) is a biologic approved in the U.S., EU, Canada, Australia and Japan for the treatment of adult Dupuytren’s contracture (DC) patients with a palpable cord, and in the U.S. and EU for the treatment of adult men with Peyronie's disease (PD).

Combining HA Fillers With Neurotoxin Slows HA Degradation

Combining HA Fillers With Neurotoxin Slows HA Degradation

Researchers in Turkey seeking to address early degradation of hyaluronic acid (HA) fillers measured HA volumes when the fillers were combined with botulinum toxin A and compared the results to the use of fillers alone.

The authors split the calvaria of a rabbit to mimic the glabellar region in humans, and applied HA alone to one side and HA combined with botulinum toxin A to the other. MRI was performed two days and three months after injection to assess the filler volumes.

Revance Reports Positive RT002 Results

Revance Reports Positive RT002 Results

Revance Therapeutics has announced positive 24-week results from its multicenter BELMONT Phase 2 active comparator study of injectable RT002 for the treatment of glabellar lines. RT002 is an injectable botulinum toxin type A investigational drug. The ongoing study has enrolled 268 subjects to compare the safety, efficacy and duration of effect of three doses of RT002 against placebo and current market leader, Botox Cosmetic (Allergan).

Lip Service

Achieving natural-looking results in perioral rejuvenation requires an examination of facial anatomy and an understanding of the wide range of treatment tools available.
Lip Service

“Marketing your expertise with lips is a very successful practice enhancer,” says cosmetic dermatologist Stephen H. Mandy, MD, of South Beach Dermatology in Miami Beach, Florida. That’s not surprising given the focus many people put on the lips. Though the eyes may be one of the first areas to show signs of aging, the allure of sultry, full lips continues to drive young and older patients alike to seek cosmetic enhancement for the perioral area.